CTSS and neoplasm: Administration of PTX in combination with cathepsin deletion by cysteine cathepsin inhibitor (PM-OEt significantly improved the therapeutic effectiveness of PTX, suppressed metastatic burden and tumor growth, and improved late-stage survival [156].